New study tests Step-by-Step drug combo to cut side effects in myeloma

NCT ID NCT01919086

First seen Mar 21, 2026 · Last updated Apr 29, 2026 · Updated 5 times

Summary

This study tested a new approach for treating multiple myeloma, a type of blood cancer. Instead of giving three strong drugs together from the start, doctors first gave two drugs (bortezomib and dexamethasone). Only if the disease did not respond well was a third drug (lenalidomide) added. The goal was to see if this step-by-step method could be just as effective but with fewer side effects. The study involved 30 adults with newly diagnosed multiple myeloma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hartford Healthcare Cancer Institute @ Hartford Hospital

    Hartford, Connecticut, 06102, United States

  • Memorial Sloan Kettering Cancer Center

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Cancer Center @ Suffolk

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Westchester

    Harrison, New York, 10604, United States

  • Memorial Sloan Kettering at Mercy Medical Center

    Rockville Centre, New York, United States

Conditions

Explore the condition pages connected to this study.